Prof. Jonathan Stevenson, Consultant Orthopaedic Oncology & Arthroplasty Surgeon

Prof. Jonathan Stevenson

Consultant Orthopaedic Oncology & Arthroplasty Surgeon

Prof. Jonathan Stevenson MB ChB FRCS (Tr&Orth)

Consultant Orthopaedic Oncology & Arthroplasty Surgeon

MB ChB FRCS (Tr&Orth)

Prof. Jonathan Stevenson

Consultant Orthopaedic Oncology & Arthroplasty Surgeon MB ChB FRCS (Tr&Orth)

MB ChB FRCS (Tr&Orth)

Areas of expertise

  • Arthritis (hip & knee)
  • Painful hip and knee replacements
  • Prosthetic joint Infection
  • Bone sarcoma & metastatic bone disease
  • Benign bone & soft-tissue tumours

Address

About Prof. Jonathan Stevenson

GMC number: 6122414

Year qualified: 2005

Place of primary qualification: University of Birmingham

Initial consultation fee: £200

Follow up consultation fee: £120

Prof. Jonathan Stevenson is a consultant orthopaedic surgeon specialising in orthopaedic oncology and complex arthroplasty. He has expertise in pelvic surgery and reconstruction, revision hip and knee replacement and prosthetic joint infection. He treats adult and paediatric bone and soft tissue sarcomas, bone metastases, benign bone and soft tissue tumours, arthritis, osteoarthritis, lipomas, schwannomas and nerve tumours. In 2015 he was appointed at the Royal Orthopaedic Hospital NHS Trust, Birmingham, where he is also a Senior Honorary Clinical Lecturer in Orthopaedics at Aston University. He serves as clinical lead for sarcoma genomics, metastatic bone disease and the research tissue bank at the Royal Orthopaedic Hospital, and was elected clinical lead for the National Cancer Research Institute bone metastases group in 2015.

He is principal investigator on studies into osseointegration of endoprosthetic replacements and bacterial fluorescence in prosthetic joint infection. Prof. Stevenson has received multiple awards, including the British Orthopaedic Association International Travelling Fellowship (2014), the British Orthopaedic Oncology Society European Travelling Fellowship (2015), and an American British Canadian Travelling Fellowship. He was awarded a level 7 certificate in strategic management and leadership and completed the BOA clinical leadership programme.

He is an active researcher, with over 100 peer reviewed publications, more than 1000 citations, six book chapters and coeditor of an orthopaedic basic sciences textbook. He presents regularly at international conferences and reviews for several orthopaedic and oncology journals. In 2023 he received a National Institute for Health and Care Research (NIHR) grant to lead the first UK clinical trial in surgically treated metastatic bone disease. He holds trustee and clinical lead roles with the Bone Cancer Research Trust and Bone Metastasis Research Collaborative. He practices at The Harborne Hospital (HCA Healthcare UK) in Birmingham, and also offers private and NHS care at the Royal Orthopaedic Hospital. His appointment year is 2015.

Areas of expertise

  • Acetabular reconstruction
  • Arthritis (hip)
  • Arthritis (knee)
  • Benign bone tumour
  • Benign soft tissue tumour
  • Biopsy (musculoskeletal)
  • Bone metastases
  • Bone sarcoma
  • Bone tumour surgery
  • Complex arthroplasty
  • Custom-made knee replacement
  • En-bloc excision bone sarcoma
  • Endoprosthetic replacement
  • Endoprosthetic replacement acetabular
  • Excision of soft tissue masses
  • Hip replacement
  • Joint replacement
  • Knee pain
  • Knee replacement
  • Limb salvage surgery
  • Lipoma
  • Lipoma removal
  • Musculoskeletal tumour surgery
  • Nerve tumours
  • Osteoarthritis
  • Pelvic reconstruction
  • Prosthetic joint infection
  • Reconstruction biopsy (musculoskeletal)
  • Revision endoprosthetic replacement
  • Revision hip surgery
  • Revision knee replacement
  • Revision surgery
  • Sarcoma
  • Schwannoma
  • Soft tissue sarcoma surgery
  • Total knee replacement

Frequently asked questions

  • Why did you decide to become a Consultant Orthopaedic Oncology & Arthroplasty Surgeon ?

    I was initially attracted to trauma surgery but fell in love with orthopaedic oncology during my training because the patients are so deserving and genuinely grateful.

  • What are the common symptoms that your patients tend to present with?

    Bone and soft tissue tumours are often painless swelling at first that became painful.

    Painful knee and hip replacements often never felt right after surgery or were perfectly fine for years then became painfully swollen or wobbly (unstable).

  • What are the treatments that you're able to offer your patients?

    For oncology patients were arrange appropriate imaging and diagnostic biopsies. For painful hip and knee replacements we use X-rays and diagnostic aspirations to rule out prosthetic joint infection.

  • What are your areas of sub-specialist interest?

    Bone metastases, bone and soft tissue sarcoma, revision hip and knee replacements, prosthetic joint infection.

  • Professional memberships

    British Orthopaedic Association
    British Orthopaedic Oncology Society
    British Medical Association (BMA)
    Royal College of Surgeons of England
    General Medical Council

    Articles by Prof. Jonathan Stevenson

    Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries

    The role of surgical margins in chondrosarcoma

    Whole-body magnetic resonance imaging in myxoid liposarcoma

    Outcome of surgery for primary and recurrent desmoid-type fibromatosis

    Surgical Innovation in Sarcoma Surgery

    Malignant bone tumours of the foot

    Bone metastases of the hand

    Impact of specialist management on survival from radiation-associated angiosarcoma of the breast

    Minimising aseptic loosening in extreme bone resections

    Navigation in Musculoskeletal Oncology: An Overview